Oncolytic virus-mediated reducing of myeloid-derived suppressor cells enhances the efficacy of PD-L1 blockade in gemcitabine-resistant pancreatic cancer
Yoshinori Kajiwara, Hiroshi Tazawa, Motohiko Yamada, Nobuhiko Kanaya, Takuro Fushimi, Satoru Kikuchi, Shinji Kuroda, Toshiaki Ohara, Kazuhiro Noma, Ryuichi Yoshida, Yuzo Umeda, Yasuo Urata, Shunsuke Kagawa, Toshiyoshi Fujiwara
Topics & Concepts
Oncolytic virusGemcitabinePancreatic cancerBlockadeCancer researchMyeloid-derived Suppressor CellVirusMedicineSuppressorCancerImmunologyInternal medicineTumor cellsReceptorCancer Research and TreatmentsVirus-based gene therapy researchCAR-T cell therapy research